Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.

Carelli S, Giallongo T, Viaggi C, Gombalova Z, Latorre E, Mazza M, Vaglini F, Di Giulio AM, Gorio A.

ASN Neuro. 2016 Oct 27;8(5). pii: 1759091416676147. Print 2016 Oct.

2.

Migration of bone marrow progenitor cells in the adult brain of rats and rabbits.

Dennie D, Louboutin JP, Strayer DS.

World J Stem Cells. 2016 Apr 26;8(4):136-57. doi: 10.4252/wjsc.v8.i4.136. Review.

3.

Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation.

Lee CT, Bendriem RM, Kindberg AA, Worden LT, Williams MP, Drgon T, Mallon BS, Harvey BK, Richie CT, Hamilton RS, Chen J, Errico SL, Tsai SY, Uhl GR, Freed WJ.

Cell Rep. 2015 Feb 3;10(4):616-32. doi: 10.1016/j.celrep.2014.12.050. Epub 2015 Jan 29.

4.

The hTH-GFP reporter rat model for the study of Parkinson's disease.

Iacovitti L, Wei X, Cai J, Kostuk EW, Lin R, Gorodinsky A, Roman P, Kusek G, Das SS, Dufour A, Martinez TN, Dave KD.

PLoS One. 2014 Dec 2;9(12):e113151. doi: 10.1371/journal.pone.0113151. eCollection 2014 Dec 2.

5.

Differentiation of rhesus adipose stem cells into dopaminergic neurons.

Zhou Y, Sun M, Li H, Yan M, Xie T.

Neural Regen Res. 2012 Dec 5;7(34):2645-52. doi: 10.3969/j.issn.1673-5374.2012.34.001.

6.

Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.

Ganz J, Arie I, Buch S, Zur TB, Barhum Y, Pour S, Araidy S, Pitaru S, Offen D.

PLoS One. 2014 Jun 19;9(6):e100445. doi: 10.1371/journal.pone.0100445. eCollection 2014 Jun 19.

7.

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.

Yan M, Sun M, Zhou Y, Wang W, He Z, Tang D, Lu S, Wang X, Li S, Wang W, Li H.

PLoS One. 2013 May 28;8(5):e64000. doi: 10.1371/journal.pone.0064000. Print 2013.

8.

BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells.

Cai J, Schleidt S, Pelta-Heller J, Hutchings D, Cannarsa G, Iacovitti L.

Dev Biol. 2013 Apr 1;376(1):62-73. doi: 10.1016/j.ydbio.2013.01.012. Epub 2013 Jan 23.

9.

Ectopic pregnancy-derived human trophoblastic stem cells regenerate dopaminergic nigrostriatal pathway to treat parkinsonian rats.

Lee TT, Tsai CF, Hsieh TH, Chen JJ, Wang YC, Kao MC, Wu RM, Singh S, Tsai EM, Lee JN.

PLoS One. 2012;7(12):e52491. doi: 10.1371/journal.pone.0052491. Epub 2012 Dec 21.

10.

Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.

Hayashi T, Wakao S, Kitada M, Ose T, Watabe H, Kuroda Y, Mitsunaga K, Matsuse D, Shigemoto T, Ito A, Ikeda H, Fukuyama H, Onoe H, Tabata Y, Dezawa M.

J Clin Invest. 2013 Jan;123(1):272-84. doi: 10.1172/JCI62516. Epub 2012 Dec 3.

11.

Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.

Aguila JC, Hedlund E, Sanchez-Pernaute R.

Stem Cells Int. 2012;2012:412040. doi: 10.1155/2012/412040. Epub 2012 Sep 4.

12.

Specification of midbrain dopamine neurons from primate pluripotent stem cells.

Xi J, Liu Y, Liu H, Chen H, Emborg ME, Zhang SC.

Stem Cells. 2012 Aug;30(8):1655-63. doi: 10.1002/stem.1152.

13.

Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease.

Roessler R, Boddeke E, Copray S.

Stem Cell Rev. 2013 Aug;9(4):505-13. doi: 10.1007/s12015-012-9369-4. Review.

14.

Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.

Sánchez-Danés A, Consiglio A, Richaud Y, Rodríguez-Pizà I, Dehay B, Edel M, Bové J, Memo M, Vila M, Raya A, Izpisua Belmonte JC.

Hum Gene Ther. 2012 Jan;23(1):56-69. doi: 10.1089/hum.2011.054. Epub 2011 Nov 17.

15.

Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons.

Deleidi M, Cooper O, Hargus G, Levy A, Isacson O.

PLoS One. 2011;6(5):e19926. doi: 10.1371/journal.pone.0019926. Epub 2011 May 31.

16.

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.

Vaccarino FM, Stevens HE, Kocabas A, Palejev D, Szekely A, Grigorenko EL, Weissman S.

Neuropharmacology. 2011 Jun;60(7-8):1355-63. doi: 10.1016/j.neuropharm.2011.02.021. Epub 2011 Mar 1. Review.

17.

Gli1 is an inducing factor in generating floor plate progenitor cells from human embryonic stem cells.

Denham M, Thompson LH, Leung J, Pébay A, Björklund A, Dottori M.

Stem Cells. 2010 Oct;28(10):1805-15. doi: 10.1002/stem.510.

18.

Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E, Lee K, Levy A, Perez-Torres E, Yow A, Isacson O.

Mol Cell Neurosci. 2010 Nov;45(3):258-66. doi: 10.1016/j.mcn.2010.06.017. Epub 2010 Jul 24.

19.
20.

Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats.

Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L.

Stem Cells Dev. 2010 Jul;19(7):1017-23. doi: 10.1089/scd.2009.0319.

Supplemental Content

Support Center